Enhancement of the liver and pancreas in the hepatic arterial dominant phase: Comparison of hepatocyte‐specific MRI contrast agents,gadoxetic acid and gadobenate dimeglumine,on 3 and 1.5 tesla MRI in the same patient

Purpose:

To evaluate the relative enhancement of liver, pancreas, focal nodular hyperplasia (FNH), pancreas‐to‐liver index, and FNH‐to‐liver index in the hepatic arterial dominant phase (HADP) after injection of hepatocyte‐specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla (T) MRI in the same patient.

Materials and Methods:

The MRI database was retrospectively searched to identify consecutive patients who underwent abdominal MRI at 3T and 1.5T systems, using both 0.025 mmol/kg gadoxetic acid‐enhanced and 0.05 mmol/kg gadobenate dimeglumine‐enhanced MRI at the same magnetic strength field system. 22 patients were identified, 10 were scanned at 3T system and 12 at 1.5T system. The enhancement of liver, pancreas, and FNH was evaluated quantitatively on MR images.

Results:

The relative enhancement of liver in HADP in the gadobenate dimeglumine‐enhanced group in all subjects was significantly higher than that in gadoxetic acid‐enhanced group (P = 0.023). The gadobenate dimeglumine‐enhanced group in HADP had better relative enhancement of pancreas and FNH, pancreas‐to‐liver index, and FNH‐to‐liver index than gadoxetic acid‐enhanced group, but the difference was not statistically significant.

Conclusion:

The 0.05 mmol/kg gadobenate dimeglumine‐enhanced abdominal MRI studies at 3T and 1.5T MR systems are superior in relative enhancement of the liver in HADP to 0.025 mmol/kg gadoxetic acid‐enhanced MRI. This type of assessment may provide comparative effectiveness data. J. Magn. Reson. Imaging 2013;37:903–908. © 2012 Wiley Periodicals, Inc.     

Gadoxetic acid-enhanced T1-weighted MR cholangiography in primary sclerosing cholangitis

Purpose:

To investigate the value of gadoxetic acid‐enhanced three‐dimensional T1‐weighted MR cholangiography (T1w‐MRC) in comparison to three‐dimensional T2‐weighted MR cholangiopancreaticography (T2w‐MRCP) in patients with primary sclerosing cholangitis (PSC).

Materials and Methods:

Thirty‐four MR exams in 29 patients (46.0 ± 16.1 years; 19 men, 10 women) scanned within a 14‐month period were retrospectively included. Two abdominal radiologists independently evaluated image quality regarding image contrast, image quality degradation due to artifacts, and visualization quality of ducts. The order of biliary tree branches that were visualized and reader preference toward each method were recorded. Helpfulness of T1w‐MRC was scored in consensus. Confirmatory endoscopic retrograde cholangiopancreaticography (ERCP) performed within 3 months of the MR examination was available in 8 patients.

Results:

Image quality of T1w‐MRC and T2w‐MRCP was graded good to excellent in all cases. There were advantages for both T1w‐MRC (functional information, less degradation due to artifacts) and T2w‐MRCP (higher order of visualized branches, better branch depiction). Both readers showed preference for T2w‐MRCP; however, both readers found gadoxetic acid–enhanced T1w‐MRC helpful in the majority of cases.

Conclusion:

Gadoxetic acid‐enhanced T1w‐MRC is complementary to, but should not replace, T2w‐MRCP. T1w‐MRC is a useful adjunct to T2w‐MRCP for morphologic evaluation and provides additional diagnostic information. J. Magn. Reson. Imaging 2012;36:632–640. © 2012 Wiley Periodicals, Inc.     

Consensus report from the 6th International forum for liver MRI using gadoxetic acid

As the utility of liver‐specific magnetic resonance imaging (MRI) increases, it is pertinent to optimize and expand protocols to improve accuracy and foster evolution of techniques; in turn, positive impacts should be seen in patient management. This article reports on the latest expert thinking and current evidence in the field of liver‐specific MRI, as discussed at the 6^th International Forum for Liver MRI, which was held in Vancouver, Canada in September 2012. Topics discussed at this forum described the use of gadoxetic acid‐enhanced MRI for the assessment of liver function at the segmental level; to increase accuracy in the diagnosis of liver metastases; to overcome current challenges in patients with cirrhosis, including management of arterial hypo‐/isovascular, hepatobiliary phase hypointense nodules; and the data which would be required in order to recommend the use of this modality in hepatocellular carcinoma management guidelines. Growing evidence suggests that gadoxetic acid‐enhanced MRI can help to improve the management of patients with a number of different liver disorders; however, more data are needed in some areas, and there may be a case for developing an interpretation guideline for gadoxetic acid‐enhanced MRI findings to aid standardization. J. Magn. Reson. Imaging 2014;40:516–529 . © 2013 Wiley Periodicals, Inc .     

Distinguishing hemangiomas from malignant solid hepatic lesions: a comparison of heavily T2-weighted images obtained before and after administration of gadoxetic acid

Purpose:

To compare the use of heavily T2‐weighted images obtained before and after administration of gadoxetic acid in differentiating hemangiomas from malignant solid hepatic lesions.

Materials and Methods:

Heavily T2‐weighted images (TE = 150 msec) were obtained for 70 patients (42 men and 28 women) with 74 focal hepatic lesions (25 hepatocellular carcinomas [HCC], 22 metastases, and 27 hemangiomas) ≤3 cm in diameter before and after gadoxetic acid‐enhanced dynamic magnetic resonance imaging (MRI). Quantitative analysis was performed using receiver operating characteristic (ROC) curves with lesion‐to‐liver signal intensity difference‐to‐noise ratio (SDNR) on precontrast and postcontrast images. Qualitative analysis was also performed by two blinded reviewers.

Results:

The SDNR of the solid lesions was significantly higher on the postcontrast (1.66 ± 1.18) than on the precontrast (1.38 ± 1.07) images (P = 0.0012), while the SDNR of hemangiomas was comparable for pre‐ and postcontrast images (P = 0.8164). The best SDNR cutoff values for distinguishing solid lesions from hemangiomas were ≤1.85 (Az = 0.948) for precontrast and ≤2.58 (Az = 0.901) for postcontrast images (P = 0.057). Reader performances for distinguishing hemangiomas from solid lesions were comparable between the precontrast (Az = 0.975 and 0.970 for readers 1 and 2) and postcontrast (Az = 0.977 and 0.972) images (P = 0.899 and 0.946).

Conclusion:

Heavily T2‐weighted images obtained after administration of gadoxetic acid have a diagnostic capability comparable to precontrast images for differentiating between small hemangiomas and malignant solid lesions of the liver. J. Magn. Reson. Imaging 2011;. © 2011 Wiley‐Liss, Inc.     

Characterization of hyperintense nodules on precontrast T1-weighted MRI: utility of gadoxetic acid-enhanced hepatocyte-phase imaging

Purpose:

To evaluate the utility of gadoxetic acid‐enhanced hepatocyte‐phase magnetic resonance imaging (MRI) in characterization of T1‐weighted hyperintense nodules within cirrhotic liver.

Materials and Methods:

This retrospective study was approved by our Institutional Review Board. Thirty‐four nodules hyperintense in unenhanced T1‐weighted MRI with histopathological confirmation from a collection of 19 patients were included. Tumor size, signal intensity on T1‐weighted, and T2‐weighted imaging as well as enhancement patterns on contrast‐enhanced dynamic/hepatocyte‐phase imaging were recorded. Receiver operating characteristic (ROC) analysis was used to evaluate the diagnostic performance of hepatocyte‐phase imaging.

Results:

Evaluation of the nodules with standard of reference revealed 15 dysplastic nodules (DN), seven well‐differentiated hepatocellular carcinomas (wHCC), and 12 moderately differentiated HCCs (mHCC). The mean size of dysplastic nodules was smaller than that of HCCs (P < 0.001). Using the HCC criteria (T2W or arterial enhancement followed with portal venous washout), 11/19 HCC were correctly characterized. Using solely hypointensity (compared to the surrounding liver parenchyma) during the hepatocyte phase as the criterion, 18/19 HCC were correctly characterized. There were seven additional HCCs diagnosed with hepatocyte‐phase imaging (P = 0.02).

Conclusion:

Gadoxetic acid‐enhanced MRI with hepatocyte‐phase imaging is superior to gadoxetic acid‐enhanced MRI with conventional criteria alone in characterization of T1W hyperintense nodules. J. Magn. Reson. Imaging 2011;33:625–632. © 2011 Wiley‐Liss, Inc.     

Comparison of high spatial resolution respiratory triggered inversion recovery‐prepared spoiled gradient echo sequence with standard breathhold T1 sequence MRI of the liver using gadoxetic acid

Purpose:

To assess if a high resolution respiratory triggered inversion recovery prepared GRE sequence (RT) improved image quality and detection of lesions compared with breathhold GRE T1 weighted MR sequence (BH) in the hepatobiliary uptake phase of MR of the liver using gadoxetic acid (Gd‐EOB‐DTPA).

Materials and Methods:

Thirty‐eight consecutive patients from July 2009 to September 2010 who had undergone Gd‐EOB‐DTPA enhanced liver exams were retrospectively identified. Qualitative assessment performed on reference lesions and background liver by two independent readers. Quantitative assessment performed by one reader.

Results:

Liver parenchyma signal‐to‐noise ratio for BH was 90.3 ± 23.9 (mean ± SD) and RT, 106.1 ± 40.4 (P = 0.119). For BH, 320 lesions were detected compared with 257 for RT. Lesion to liver contrast was significantly better on RT sequences (0.26 ± 0.24; mean ± SD) compared with BH sequence (0.21 ± 0.20; P = 0.044). Fifty‐seven reference lesions assessed. Both reviewers rated BH better for lesion margin and hepatic vessel sharpness. BH was rated with less artifact (P < 0.05). Lesion to liver contrast on BH was significantly better for one reviewer.

Conclusion:

BH sequence had better overall image quality than RT in several quantitative and qualitative factors including number of lesions detected and level of artifact. J. Magn. Reson. Imaging 2013;37:700—706. © 2013 Wiley Periodicals, Inc.     

Quantitative evaluation of liver cirrhosis using T1 relaxation time with 3 tesla MRI before and after oxygen inhalation

Purpose:

To quantify liver T1 relaxation times before and after oxygen inhalation in patients with and without liver cirrhosis using a 3 Tesla (T) MRI.

Materials and Methods:

Institutional Review Board approval and written informed consent were obtained. Ninety‐two noncirrhotic patients and 87 patients with hepatitis B viral liver cirrhosis (72 Child‐Pugh class A and 15 Child‐Pugh class B or C) underwent MRI with a 3.0T system before and after the supply of 100% oxygen at a rate of 15 L/min by means of a nonrebreather ventilation mask for 3 min. T1 maps were acquired using three‐dimensional spoiled gradient echo sequences with two different flip angles (2° and 14°) and a fixed TR/TE (2.54 ms/0.95 ms). Liver T1 values were obtained using a T1 processing tool (MapIT software). The mean baseline T1 values of three groups (control, Child‐Pugh class A, and Child‐Pugh class B/C) were compared using an analysis of variance test. Liver T1 value before and after oxygenation was compared using a paired t‐test for each group.

Results:

The baseline liver T1 value was significantly higher in the control group (941 ± 136 ms) than in Child‐Pugh A (858 ± 143 ms) and Child‐Pugh B/C (783 ± 164 ms) group (P < 0.001 and P < 0.0001). The reduction in the liver T1 value after oxygen inhalation was significant in the control group (P = 0.012) but not significant in Child‐Pugh class A (P = 0.079) and Child‐Pugh class B/C (P = 0.752).

Conclusion:

The baseline liver T1 relaxation time was significantly different between the patients with and without liver cirrhosis. The shortening effect of oxygen on the liver T1 value was significant in the control group but not in the cirrhotic patients. J. Magn. Reson. Imaging 2012;36:405–410. © 2012 Wiley Periodicals, Inc.     

Detection and characterization of focal hepatic tumors: A comparison of T2‐weighted MR images before and after the administration of gadoxectic acid

Purpose

To evaluate if T2‐weighted images (T2WI) after administration of gadoxetic acid have diagnostic capability comparable to precontrast T2WI in the detection and characterization of focal liver lesions.

Materials and Methods

Eighty patients with 128 liver lesions (71 hepatocellular carcinomas, 35 metastases, and 22 hemangiomas) underwent gadoxetic acid‐enhanced T1WI and precontrast and postcontrast turbo spin echo‐short tau inversion recovery (TSE‐STIR) and respiratory triggered (RT)‐TSE. The sensitivity for malignancy with combining T2WIs and enhanced T1WIs was evaluated and percentage of signal intensity loss (PSIL) and lesion‐liver contrast to noise ratio (CNR) were calculated for T2WIs. Lesion characterization with T2WIs as solid and nonsolid was evaluated using kappa statistics.

Results

The PSIL was higher with TSE‐STIR than with RT‐TSE (P = 0.0001). The malignancy‐liver CNRs on postcontrast T2WIs were higher than on precontrast T2WIs (P = 0.0001). Sensitivity for malignancy by combining postcontrast T2WIs and T1WIs (93.0% [hepatocellular carcinoma, HCC]; 97.1% [metastases]) was comparable to sensitivity of combining precontrast T2WIs and postcontrast T1WIs (91.6% [HCC]; 88.6% [metastases]). Kappa values for T2WIs indicated excellent agreement (k = 0.935).

Conclusion

Gadoxetic acid‐enhanced T2WIs showed a comparable diagnostic capability to precontrast T2WIs for the detection and characterization of hepatic tumors. J. Magn. Reson. Imaging 2009;30:437–443. © 2009 Wiley‐Liss, Inc.     

A T1-weighted rapid three-dimensional gradient-echo technique (MP-RAGE) in preoperative MRI of intracranial tumours

Oar purpose was to determine the value of a T1-weighted rapid three-dimensional gradientecho technique in preoperative MRI of brain tumours. We examined 30 patients with intracranial tumours who underwent neurosurgery, using T1-wighted magnetisation-prepared rapid gradient-echo (MP-RAGE) and axial T1-weighted spin-echo (SE) sequences, both before and after contrast medium (Gd-DTPA). Signal and contrast behaviour of anatomical and pathological structures were assessed with regions-of-interest (ROI) and visual inspection. Imaging results were compared with operative results. In 5 cases tumours and anatomical structure were segmented in MP-RAGE data sets. The MP-RAGE sequence considerably improved delineation of grey and white matter and small anatomical structures (vessels, cranial nerves), and significantly reduced flow artefacts. Contrast behaviour of tumours was similar with both techniques. Correlation of imaging with the operative results confirmed the reliability of the MP-RAGE sequence. Segmentation of MP-RAGE data sets allows three-dimensional display, which enables one to document the relevant information on a few images in selected cases.     

Evaluation of possible drug-drug interaction between gadoxetic acid and erythromycin as an inhibitor of organic anion transporting peptides (OATP)

Purpose

To evaluate if erythromycin compromises liver‐specific enhancement of gadoxetic acid; both compounds competing in organic anion transporting peptides (OATP) ‐mediated hepatocytic uptake.

Materials and Methods

The study was approved by institutional review board. Twelve healthy subjects (nine men, three woman; mean age, 38.7 years) were examined twice by MR imaging with prior administration of NaCl solution (placebo) or 1000 mg of erythromycin following a randomized sequence. Gadoxetic acid (0.025 mmol/kg body weight) was administered 15 min after the end of infusions. Pre‐ and 20 min postcontrast two‐dimensional gradient‐recalled‐echo sequences were acquired. Relative enhancements of liver parenchyma and ratio of means were calculated from signal intensity measurements. Plasma levels of gadoxetic acid and erythromycin were determined and given in geometric means and coefficients of variation (CV).

Results

Concentration of erythromycin directly after end of infusion was 13.9 mg/L (CV 14.9%). Gadolinium plasma concentrations 5 min after gadoxetic acid administration were 138.7 μmol/L (CV 20.4%) after erythromycin infusion and 129.6 μmol/L (CV 22.8%) after placebo. Mean relative enhancements of liver parenchyma were 88.1 (SD 24.9%) after erythromycin infusion and 92.6 (SD 17.9%) after placebo. Ratio of relative enhancements was 0.951 (95% confidence interval, 0.833; 1.061; statistically not significant).

Conclusion

Coadministration of erythromycin has no effect on gadoxetic acid enhanced liver MR imaging. J. Magn. Reson. Imaging 2011;33:409–416. © 2011 Wiley‐Liss, Inc.     

Fully automatic segmentation of the brain from T1-weighted MRI using Bridge Burner algorithm

PURPOSE: To validate Bridge Burner, a new brain segmentation algorithm based on thresholding, connectivity, surface detection, and a new operator of constrained growing. MATERIALS AND METHODS: T1-weighted MR images were selected at random from three previous neuroimaging studies to represent a spectrum of system manufacturers, pulse sequences, subject ages, genders, and neurological conditions. The ground truth consisted of brain masks generated manually by a consensus of expert observers. All cases were segmented using a common set of parameters. RESULTS: Bridge Burner segmentation errors were 3.4% +/- 1.3% (volume mismatch) and 0.34 +/- 0.17 mm (surface mismatch). The disagreement among experts was 3.8% +/- 2.0% (volume mismatch) and 0.48 +/- 0.49 mm (surface mismatch). The error obtained using the brain extraction tool (BET), a widely used brain segmentation program, was 8.3% +/- 9.1%. Bridge Burner brain masks are visually similar to the masks generated by human experts. Areas affected by signal intensity nonuniformity artifacts were occasionally undersegmented, and meninges and large sinuses were often falsely classified as the brain tissue. Segmentation of one MRI dataset takes seven seconds. CONCLUSION: The new fully automatic algorithm appears to provide accurate brain segmentation from high-resolution T1-weighted MR images.     

Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times

PURPOSE: To evaluate the different signal characteristics of focal hepatic lesions on ferumoxides-enhanced MR imaging, including T1-weighted spoiled gradient recalled echo (GRE) images using different echo times (TE) and T2- and T2*-weighted images. MATERIALS AND METHODS: Ferumoxides-enhanced MR imaging was performed using a 1.5-T system in 46 patients who were referred for evaluation of known or suspected hepatic malignancies. One hundred and seven lesions (42 hepatocellular carcinomas [HCC], 40 metastases, 13 cysts, eight hemangiomas, three focal nodular hyperplasias [FNHs], and one cholangiocarcinoma) were evaluated. Postcontrast MR imaging included 1) T2-weighted FSE; 2) T2*-weighted GRE; 3) T1-weighted spoiled GRE using moderate (TE = 4.2-4.4 msec) TE; and 4) minimum (TE = 1.8-2.1 msec) TE. Signal intensities of the focal lesions were rated by two radiologists in conference as follows: hypointense, isointense or invisible, hyperintense, and markedly hyperintense. Lesion-to-liver contrast-to-noise ratio (C/N) was measured by one radiologist for a quantitative assessment. RESULTS: On ferumoxides-enhanced FSE images, 92% of cysts were "markedly hyperintense" and most of the other lesions were "hyperintense", and the mean C/N of cysts was significantly higher than that of other focal lesions. T2*-weighted GRE images showed most lesions with similar hyperintensities and the mean C/N was not significantly different between any two types of lesion. T1-weighted GRE images using moderate TE showed all FNHsand hemangiomas, 29 (69%) HCCs and eight (20%) metastases as "hyperintense". On T1-weighted GRE images using minimum TE, however, all HCCs and metastasis except one were iso- or hypointense, while all of the FNHs and hemangiomas were hyperintense. Ring enhancement was highly suggestive of malignant lesions, and was more commonly seen on the minimum TE images than on the moderate TE images. CONCLUSION: Addition of T1-weighted GRE images using minimum and moderate TE is helpful for characterizing focal lesions in ferumoxides-enhanced MR imaging.     

Peripheral hyperintense pattern on T2-weighted magnetic resonance imaging (MRI) in breast carcinoma: correlation with early peripheral enhancement on dynamic MRI and histopathologic findings

Purpose

To assess the value of magnetic resonance (MR) diffusion‐weighted imaging (DWI) in the evaluation of deep infiltrating endometriosis (DIE).

Materials and Methods

In a prospective single‐center study, DWI was added to the standard MRI protocol in 56 consecutive patients with known or suspected endometriosis. Endometriotic lesions as well as (functional) ovarian cysts were analyzed for location, size, and signal intensity on T1, T2, and DWI. Apparent diffusion coefficient (ADC) values were calculated using b‐values of 50, 400, 800, and 1200 s/mm². Statistical analysis included the Spearman correlation coefficient, Mann–Whitney U, and Kruskal–Wallis tests.

Results

A total of 112 lesions (62 endometrial cysts and 48 DIE) were detected, 60 of which were large enough to analyze. Mean ADC values of endometrial cysts and functional ovarian cysts were 1.11 × 10^?3/mm²/s and 2.14 × 10^?3/mm²/s, respectively. Mean ADC values of DIE retrocervical, infiltrating the colon, and bladder were 0.70 × 10^?3/mm²/s, 0.79 × 10^?3/mm²/s, and 0.76 × 10^?3/mm²/s, respectively. ADC values of DIE did not show a significant difference between varying pelvic locations (P = 0.63).

Conclusion

Results of our study suggest that ADC values of DIE are consistently low, without significant difference between pelvic locations. J. Magn. Reson. Imaging 2010;31:1117–1123. © 2010 Wiley‐Liss, Inc.

     

Improvement in breast lesion characterization with dynamic contrast-enhanced MRI using pharmacokinetic modeling and bookend T(1) measurements.

Dynamic contrast-enhanced breast MR imaging was performed on 14 patients (five cancerous lesions, nine benign) with slice-selective spoiled gradient-recalled echo (2D SPGR) imaging. Adiabatic saturation recovery T(1) measurements were performed before (T(1pre)) and after (T(1post)) 2D SPGR imaging. These two "bookend" T(1) measurements were used to calibrate the equations which were employed to convert the time course of the 2D SPGR signal strength to T(1)-vs.-time, which in turn was used to compute the gadolinium concentration-vs.-time ([C](t)) in the lesion. The extraction-flow product (EF) was computed for each lesion by pharmacokinetic modeling of [C](t). For this study, EF provided a sensitivity and specificity for cancer of 100% and 78%, respectively. When only T(1pre) was used to estimate [C](t) (which assumes a priori knowledge of the shape and amplitude of the slice profile), the sensitivity and specificity fell to 80% and 56%, respectively. This is presumably due to unexpected variations in the shape and/or amplitude of the slice profile, which could be caused by factors such as patient-to-patient variations in breast geometry or inconsistently set transmit gains. Therefore, both T(1pre) and T(1post) measurements are necessary for optimum sensitivity and specificity using pharmacokinetic analysis.